Literature DB >> 7922396

Role of endogenous nitric oxide in septic shock.

P Vallance1, S Moncada.   

Abstract

Nitric oxide synthesized by a constitutive enzyme is a widespread mediator of cell-cell and intracellular communication. This mediator provides a continuous vasodilator influence in the cardiovascular system, modifies the function of circulating cells, and acts as a neurotransmitter. After exposure to bacterial endotoxin or certain cytokines, expression of a second, inducible nitric oxide synthase occurs in a wide variety of tissues. This enzyme produces large amounts of nitric oxide for long periods and has been implicated in pathophysiologic changes seen in sepsis. In some cells, including macrophages, the nitric oxide synthesized by the inducible enzyme is toxic and appears to be an important mediator in host defense. Studies in animals and in vitro have demonstrated that nitric oxide released from inducible nitric oxide synthase in other tissues may cause profound vasodilation, damage to host cells, and cardiac dysfunction. The hypotension of endotoxin- or cytokine-induced shock can be reversed by inhibitors of nitric oxide synthase and these agents may provide a novel therapeutic approach to the treatment of severe septic shock. Preliminary studies in humans suggest that inhibition of nitric oxide synthase improves BP and stabilizes hemodynamics; effects on mortality rates remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7922396

Source DB:  PubMed          Journal:  New Horiz        ISSN: 1063-7389


  16 in total

Review 1.  Nitric oxide: discovery and impact on clinical medicine.

Authors:  S Moncada
Journal:  J R Soc Med       Date:  1999-04       Impact factor: 5.344

Review 2.  Is sepsis a mediator-inhibitor mismatch?

Authors:  M Lamy; G Deby-Dupont
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

Review 3.  Nitric oxide in the human cardiovascular system--SKB lecture 1997.

Authors:  P Vallance
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

4.  Inducible nitric oxide synthase in the cardiovascular system.

Authors:  K Bhagat; P Vallance
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

5.  Constriction of rat extra-splenic veins to lipopolysaccharide involves endothelin-1.

Authors:  Arnaud Mansart; Lewis J Ruff; Mark P Ariaans; Jonathan J Ross; Charles S Reilly; Nicola J Brown; Susan Kaufman; Zoë L S Brookes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-16       Impact factor: 3.000

6.  Functional effects of econazole on inducible nitric oxide synthase: production of a calmodulin-dependent enzyme.

Authors:  R G Bogle; P Vallance
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 7.  Biology and clinical relevance of nitric oxide.

Authors:  P Vallance; J Collier
Journal:  BMJ       Date:  1994-08-13

8.  Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.

Authors:  M B Hussain; A J Hobbs; R J MacAllister
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 9.  Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion.

Authors:  R M Egdell; T Siminiak; D J Sheridan
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

10.  H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G.

Authors:  S Muzaffar; J Y Jeremy; A Sparatore; P Del Soldato; G D Angelini; N Shukla
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.